Boundless Bio: An Underestimated Biotech With A First-In-Class EcDNA Targeted Kinesin Degrader
seekingalpha.com
Want to monitor INVA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor INVAinnoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals.